tetradecanoylphorbol acetate has been researched along with n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argade, A; Baluom, M; Braselmann, S; Grossbard, EB; Herlaar, E; Jurcevic, S; Lau, A; Lovell, S; Masuda, ES; Park, G; Payan, DG; Pine, P; Qu, K; Singh, R; Sun, T; Sylvain, C; Taylor, V; Wang, S; Wong, BR; Young, C; Zhao, H | 1 |
1 trial(s) available for tetradecanoylphorbol acetate and n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine
| Article | Year |
|---|---|
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
Topics: Animals; Antigen-Antibody Complex; Arthritis, Experimental; Arthus Reaction; B-Lymphocytes; Basophils; Blotting, Western; Cells, Cultured; Crystallography; Double-Blind Method; Enzyme Inhibitors; Fluorescence Polarization Immunoassay; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharides; Macrophages; Mast Cells; Mice; Mice, Inbred BALB C; Oxazines; Platelet Aggregation; Protein-Tyrosine Kinases; Pyridines; Receptors, Fc; Signal Transduction; Spleen; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 2006 |